Fenton H McCarthy1, Dale Kobrin1, J Eduardo Rame2, Peter W Groeneveld3, Katherine M McDermott1, Pavan Atluri1, Michael A Acker1, Nimesh D Desai4. 1. Division of Cardiovascular Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania. 2. Division of Cardiovascular Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania. 3. Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania. 4. Division of Cardiovascular Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania. Electronic address: nimesh.desai@uphs.upenn.edu.
Abstract
BACKGROUND: Recent reports indicate an increased prevalence and earlier onset of pump thrombosis and associated pump exchanges after left ventricular assist device (LVAD) implantation. Questions remain regarding the current rate and clinical effect of pump exchanges. METHODS: All United States Medicare fee-for-service patients undergoing LVAD implantations (n = 3,166) between January 2009 and December 2012 were identified by procedural codes present on carrier claims collected by the Centers for Medicare & Medicaid Services. Pump exchange, pump removal, heart transplantation, and death were collected from subsequent carrier claim and denominator files. Comorbidities present before implantation were generated using the Elixhauser comorbidity index. RESULTS: Compared with patients who received LVADs before March 1, 2011, LVAD recipients after March 1, 2011, were older on average (63.9 vs 62.2 years, p < 0.01), more likely to be male (82.3% vs. 79.4%, p = 0.04), and had a higher incidence of common comorbidities. The later cohort had higher occurrence of pump exchange by Kaplan-Meier time-to-event estimates and Fisher exact tests at 3 months (1.8 vs 0.8, p = 0.02), 6 months (3.3 vs 1.0, p < 0.01), and 12 months (4.9 vs 2.2, p < 0.01). Cox regression analysis found time-dependent pump exchange was associated with worse survival (hazard ratio, 2.5; 95% confidence interval, 1.8 to 3.62; p < 0.01) after adjusting for age, gender, and comorbidities. CONCLUSIONS: Although LVAD exchanges remain relatively uncommon, a significant increase in the incidence of the procedure has occurred since March 1, 2011. Pump exchanges are highly associated with death, and further research is required to understand the cause of this disturbing trend and surveillance to determine its trajectory.
BACKGROUND: Recent reports indicate an increased prevalence and earlier onset of pump thrombosis and associated pump exchanges after left ventricular assist device (LVAD) implantation. Questions remain regarding the current rate and clinical effect of pump exchanges. METHODS: All United States Medicare fee-for-service patients undergoing LVAD implantations (n = 3,166) between January 2009 and December 2012 were identified by procedural codes present on carrier claims collected by the Centers for Medicare & Medicaid Services. Pump exchange, pump removal, heart transplantation, and death were collected from subsequent carrier claim and denominator files. Comorbidities present before implantation were generated using the Elixhauser comorbidity index. RESULTS: Compared with patients who received LVADs before March 1, 2011, LVAD recipients after March 1, 2011, were older on average (63.9 vs 62.2 years, p < 0.01), more likely to be male (82.3% vs. 79.4%, p = 0.04), and had a higher incidence of common comorbidities. The later cohort had higher occurrence of pump exchange by Kaplan-Meier time-to-event estimates and Fisher exact tests at 3 months (1.8 vs 0.8, p = 0.02), 6 months (3.3 vs 1.0, p < 0.01), and 12 months (4.9 vs 2.2, p < 0.01). Cox regression analysis found time-dependent pump exchange was associated with worse survival (hazard ratio, 2.5; 95% confidence interval, 1.8 to 3.62; p < 0.01) after adjusting for age, gender, and comorbidities. CONCLUSIONS: Although LVAD exchanges remain relatively uncommon, a significant increase in the incidence of the procedure has occurred since March 1, 2011. Pump exchanges are highly associated with death, and further research is required to understand the cause of this disturbing trend and surveillance to determine its trajectory.
Authors: Diyar Saeed; Bujar Maxhera; Alexander Albert; Ralf Westenfeld; Till Hoffmann; Artur Lichtenberg Journal: Interact Cardiovasc Thorac Surg Date: 2016-03-18
Authors: Martin I Sigurdsson; Nicholas T Longford; Mahyar Heydarpour; Louis Saddic; Tzuu-Wang Chang; Amanda A Fox; Charles D Collard; Sary Aranki; Prem Shekar; Stanton K Shernan; Jochen D Muehlschlegel; Simon C Body Journal: Ann Thorac Surg Date: 2016-07-15 Impact factor: 4.330
Authors: Justin M Bachmann; Meredith S Duncan; Ashish S Shah; Robert A Greevy; JoAnn Lindenfeld; Steven J Keteyian; Randal J Thomas; Mary A Whooley; Thomas J Wang; Matthew S Freiberg Journal: JACC Heart Fail Date: 2018-02 Impact factor: 12.035
Authors: Hideki Tsubota; Roberto V P Ribeiro; Filio Billia; Robert J Cusimano; Terrence M Yau; Mitesh V Badiwala; William E Stansfield; Vivek Rao Journal: Can J Surg Date: 2017-08 Impact factor: 2.089
Authors: Jessica Howard-Anderson; Stephanie M Pouch; Mary Elizabeth Sexton; Aneesh K Mehta; Andrew L Smith; George M Lyon; Rachel Friedman-Moraco Journal: Open Forum Infect Dis Date: 2019-09-04 Impact factor: 3.835